0000899243-20-004301.txt : 20200212 0000899243-20-004301.hdr.sgml : 20200212 20200212170752 ACCESSION NUMBER: 0000899243-20-004301 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200210 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARDNER JASON CENTRAL INDEX KEY: 0001741286 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38541 FILM NUMBER: 20605288 MAIL ADDRESS: STREET 1: C/O MAGENTA THERAPEUTICS STREET 2: 50 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Magenta Therapeutics, Inc. CENTRAL INDEX KEY: 0001690585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-10 0 0001690585 Magenta Therapeutics, Inc. MGTA 0001741286 GARDNER JASON C/O MAGENTA THERAPEUTICS, INC. 100 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 1 0 0 See Remarks Stock Option (Right to Buy) 12.28 2020-02-10 4 A 0 275000 0.00 A 2030-02-09 Common Stock 275000 275000 D This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020. Title: President and Chief Executive Officer /s/ Zoran Zdraveski, Attorney-in-Fact for Jason Gardner 2020-02-12